Atossa Therapeutics, Inc.
ATOS
$2.40
-$0.12-4.57%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -25.42% | -3.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.91% | -13.69% | |||
| Operating Income | 11.91% | 13.69% | |||
| Income Before Tax | 11.45% | 12.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.45% | 12.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.45% | 12.33% | |||
| EBIT | 11.91% | 13.69% | |||
| EBITDA | 11.92% | 13.70% | |||
| EPS Basic | 14.30% | 12.44% | |||
| Normalized Basic EPS | 14.30% | 12.43% | |||
| EPS Diluted | 14.30% | 12.44% | |||
| Normalized Diluted EPS | 14.30% | 12.43% | |||
| Average Basic Shares Outstanding | 3.32% | 0.13% | |||
| Average Diluted Shares Outstanding | 3.32% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||